IFNAR1 and fatty liver disease: Notably, mice knockout of IFN-α/β receptor subunit 1 (IFNAR1)−/− fed on HFD were protected from IR and hepatic steatosis, whereas administration of anti-IFNAR1 antibody in the same mouse model improved glucose tolerance and IR, although body weight did not change [118].